Pathology News


By Duane Newton | 6 July

Technological advances have contributed significantly to improved detection rates of important microbial pathogens. Matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry, historically used in only in clinical chemistry laboratories, is now improving diagnostic speed and accuracy in clinical microbiology laboratories.

The primary goal of the Clinical Microbiology Laboratory is to identify causative agents of infectious diseases in patient specimens. Traditionally, this is achieved by first isolating an organism in culture and using a variety of different physical and chemical features of the organism to identify it. However, the identification procedures can be time-consuming and cumbersome, often requiring days before the final result is available. MALDI-TOF mass spectrometry has recently emerged as an important, rapid and accurate tool for organism identification, providing results in just a few minutes.

Once an organism is isolated from a clinical specimen, a small amount is spotted on a stainless steel target plate, mixed with a chemical matrix and allowed to dry. When placed into the MALDI-TOF instrument, the spot on the target plate is subjected to laser pulses. The now desorbed ionized molecules from the isolate are accelerated through a flight tube by an electromagnetic field. The TOF of the analytes to the detector is then measured and produces a characteristic spectrum from which an organism can be identified. This is accomplished by comparing the resultant spectrum to a database containing spectral patterns of various clinically-relevant organisms. The software then matches the spectrum in question, providing an identification.

Diagram of process.
MALDI-TOF mass spectrometry is suitable for the microbiology laboratories because samples require minimal preparation and identifications are made in less than one minute. MALDI-TOF also provides excellent specificity, low operating costs, and requires minimal maintenance. The identification database is continuously updated with clinically-relevant organisms to improve the diagnostic capacity of the system.

Although this technology is powerful, there are a few limitations. The database is not entirely complete, so not all organisms are able to be identified (<5% unidentified). In addition, the acquisition costs of the instrument are high; but because of the extremely low operating costs, and the high volume of samples that can be tested on the system, the return on investment can be relatively quick.

In collaboration with our institutional Antimicrobial Stewardship Team (AST), we have recently published a study* demonstrating that rapid identification of isolates using MALDI-TOF yields clinically-significant benefits to our patients and health system overall when coupled with active AST interventions. Not only were microbiology reporting times reduced, but patients whose cultures were identified using MALDI-TOF had significantly shorter times to placement on optimal antimicrobial therapy, reduced length-of-stay, and reduced mortality compared to patients whose cultures were identified using conventional methods.

This recent implementation of MALDI-TOF in the Clinical Microbiology Laboratory has clearly demonstrated positive clinical and operational impacts, and is serving as a template for the continued incorporation of the latest technology in our clinical microbiology laboratory.


*Huang AM, Newton DW, Kunapuli A, Gandhi TN, Washer LL, Isip J, Collins CD, Nagel JL. 2013. Rapid Organism Identification via Matrix-Assisted Laser Desorption Ionization Time-of-Flight Combined with Antimicrobial Stewardship Team Intervention Decreases Mortality and Improves Time to Clinical Response in Adult Patients with Bacteremia and Candidemia. Clinical Infectious Diseases. 57:1237-45.

Rate this Article: